Preoperative Chemotherapy and Radiation for Borderline Resectable Pancreatic Cancer (JAMA Surgery)
Interview with Matthew H. G. Katz, MD, author of Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101
Source: JAMA Specialty Journals Author Interviews - Category: Journals (General) Authors: The JAMA Network Source Type: podcasts
More News: Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | General Medicine | Pancreas | Pancreatic Cancer | Xeloda